OTLK
Outlook Therapeutics, Inc.Company with tickers: OTLK
CIK
1649989
CUSIP
69012T305
Shares Outstanding
120,863,252
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $-1,259,347 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | — | ||||
| Research & Development | $8,134,872 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-27,510,939 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-27,511,216 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.39 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.39 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |